Wird geladen...
EGFR/HER-targeted therapeutics in ovarian cancer
Despite decades of research and evolving treatment modalities, survival among patients with epithelial ovarian cancer has improved only incrementally. During this same period, the development of biologically targeted therapeutics has improved survival for patients with diverse malignancies. Many of...
Gespeichert in:
| Veröffentlicht in: | Future Med Chem |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4620931/ https://ncbi.nlm.nih.gov/pubmed/22416774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.12.11 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|